| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.480 | 19.856 | 27.896 | 31.021 | 34.910 | 30.535 | 47.969 | 50.796 | 55.421 | 70.191 |
| Total Income - EUR | 13.593 | 19.856 | 27.896 | 31.034 | 35.436 | 30.535 | 47.969 | 50.796 | 55.421 | 70.191 |
| Total Expenses - EUR | 7.720 | 17.589 | 15.591 | 13.477 | 15.978 | 19.601 | 20.208 | 21.275 | 29.905 | 26.666 |
| Gross Profit/Loss - EUR | 5.873 | 2.267 | 12.304 | 17.557 | 19.459 | 10.934 | 27.761 | 29.521 | 25.516 | 43.524 |
| Net Profit/Loss - EUR | 5.465 | 1.671 | 11.467 | 16.632 | 18.395 | 10.267 | 26.351 | 28.261 | 25.028 | 36.518 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Oftalmomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.722 | 18.273 | 15.315 | 17.630 | 42.577 | 36.357 | 26.893 | 21.468 | 13.883 | 14.514 |
| Current Assets | 523 | 1.833 | 15.629 | 29.369 | 22.165 | 37.047 | 36.343 | 21.494 | 52.023 | 50.553 |
| Inventories | 0 | 0 | 0 | 64 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 67 | 67 | 66 | 0 | 0 | 0 | 0 | 0 | 61 | 60 |
| Cash | 456 | 1.767 | 15.563 | 29.304 | 22.165 | 37.047 | 36.343 | 21.494 | 51.963 | 50.493 |
| Shareholders Funds | 16.188 | 17.694 | 28.862 | 44.965 | 62.489 | 71.572 | 60.906 | 28.310 | 53.252 | 36.566 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.057 | 2.412 | 2.082 | 2.035 | 2.253 | 1.833 | 2.331 | 14.652 | 12.654 | 28.501 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftalmomed Srl